January 25 2012 - Amorcyte, a NeoStem Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction
January 10, 2012 - Amorcyte, a NeoStem Company, Announces Expansion of Intellectual Property Coverage
October 17, 2011 - NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
August 15, 2011 - NeoStem Provides Update on Amorcyte Clinical Progress and Reports Results for Second Quarter
July 14, 2011 - NeoStem Signs Definitive Merger Agreement to Acquire Amorcyte in Equity Transaction
For more Amorcyte news please visit www.amorcyte.com.
Quick Links
Copyright © 2010-2012 NeoStem, Inc.
Privacy Policy | Forward Looking Statements | Terms of Use | Social Media Policy | Site Map
